Babraham Investor Conference (BIC) is a must attend one-day conference for investors focusing on early-stage and scale-up life science and med-tech companies from across the UK and Europe. It takes place on Wednesday 15th May 2019 at the Babraham Research Campus, Cambridge, UK.
Babraham Investor Conference 2019 - registration closes 10th May
BIC strives to present a broad spectrum of investment opportunities with sessions focused on scale-up and venture-stage growth companies, those beyond start-up and those which are in or entering the growth stage of their development. The event features a rich programme of company presentations, networking opportunities and one to one meetings.
BIC 2019 is taking place on Wednesday 15th May in The Cambridge Building on the Babraham Research Campus, Cambridge, CB22 3AT.
Dr Anne Dobree (Cambridge Enterprise), Dr Ian Tomlinson (Apollo Therapeutics) and Tamsin Berry (Office for Life Science) are speakers at the event.
Registration closes on Friday 10th May. To find out more including the programme or to register - https://www.babraham.com/bic-2019/
Babraham Bioscience Technologies Ltd (BBT) is responsible for the commercial development of the Babraham Research Campus. The Babraham Research Campus is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation. The Campus provides companies laboratory and office space together with access to outstanding scientific facilities in an ideal geographical location at the core of the Cambridge cluster.